Selventa

Selventa and Rosa plan to combine knowledge assets, proprietary data, physiologic model libraries, and expertise in several disease areas with the aim of helping clients make better drug discovery and development decisions.

The two firms' combined modeling and analysis will integrate genomic, transcriptomic, in vitro, animal, and clinical data in a quantitative model.

People In The News

Jeremy Berg is stepping down from NIGMS, Timothy Triche is named to Wafergen's scientific advisory board, and Uwe Neue has died.

The company said it will focus on providing consulting services and software, and help its clients select patient-specific treatments.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.